Holli Gwendolyn

Mash Tag 2025 Toyota. This unique conference brings together clinicians, academia, and the pharmaceutical industry to discuss the identification of appropriate patient populations, trial. These publications do not constitute.

The following publications may contain information that is not consistent with the approved prescribing information for resmetirom. Mash is a serious, chronic, and progressive condition that will soon become the leading cause of liver transplantation and a significant contributor to liver cancer development.